McDonald Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.83M | Buy |
116,796
+1,102
| +1% | +$26.7K | 0.68% | 36 |
|
|
2025
Q1 | $2.93M | Buy |
115,694
+5,398
| +5% | +$137K | 0.76% | 35 |
|
|
2024
Q4 | $2.93M | Buy |
110,296
+9,963
| +10% | +$264K | 0.75% | 37 |
|
|
2024
Q3 | $2.9M | Buy |
100,333
+9,462
| +10% | +$274K | 0.73% | 38 |
|
|
2024
Q2 | $2.54M | Buy |
90,871
+23,113
| +34% | +$647K | 0.68% | 39 |
|
|
2024
Q1 | $1.88M | Buy |
67,758
+17,939
| +36% | +$498K | 0.52% | 54 |
|
|
2023
Q4 | $1.43M | Sell |
49,819
-29,641
| -37% | -$853K | 0.43% | 72 |
|
|
2023
Q3 | $2.64M | Sell |
79,460
-6,656
| -8% | -$221K | 0.86% | 34 |
|
|
2023
Q2 | $3.16M | Sell |
86,116
-2,192
| -2% | -$80.4K | 0.97% | 26 |
|
|
2023
Q1 | $3.6M | Sell |
88,308
-5,926
| -6% | -$242K | 1.17% | 16 |
|
|
2022
Q4 | $4.83M | Sell |
94,234
-663
| -0.7% | -$34K | 1.65% | 11 |
|
|
2022
Q3 | $4.15M | Sell |
94,897
-27,163
| -22% | -$1.19M | 1.58% | 13 |
|
|
2022
Q2 | $6.4M | Sell |
122,060
-1,304
| -1% | -$68.4K | 1.63% | 7 |
|
|
2022
Q1 | $6.39M | Buy |
123,364
+123,311
| +232,662% | +$6.38M | 1.39% | 8 |
|
|
2021
Q4 | $3.13K | Sell |
53
-120,556
| -100% | -$7.12M | ﹤0.01% | 286 |
|
|
2021
Q3 | $5.19M | Sell |
120,609
-1,282
| -1% | -$55.1K | 1.22% | 15 |
|
|
2021
Q2 | $4.77M | Buy |
121,891
+4,330
| +4% | +$170K | 1.13% | 17 |
|
|
2021
Q1 | $4.26M | Sell |
117,561
-1,384
| -1% | -$50.1K | 1.09% | 16 |
|
|
2020
Q4 | $4.38M | Buy |
+118,945
| New | +$4.38M | 1.23% | 16 |
|